Australian forex and CFDs broker FP Markets has added more than 550 new stock CFDs to its already extensive list of products.
The stock CFDs come from a range of global markets including London, Hong Kong, Paris, Frankfurt, Madrid, Amsterdam, and New York (NYSE and Nasdaq) and cover a wide range of sectors including pharmaceuticals, aviation, tourism, and Big Tech and add to an offering which already includes some of the world's most popular companies such as Apple, Facebook, Tesla, Amazon, and Google.
The new instruments are available on the FP Markets Metatrader 5 (MT5) Platform.
Craig Allison, Head of Europe, Middle-East, and Africa commented:
"The interest around equities has reached an all-time high globally and it is important for us to continually evolve and expand our product range in line with increased client demand for a greater diversity of our range of share CFDs. We already have an impressive portfolio of leading global stocks including companies like Tesla and the so-called 'FAANGs.'
This exciting new product range adds an array of global companies from a wide range of sectors, on a number of international exchanges, including Alibaba, Zoom and a range of Biotech and Big Pharma companies, which have proved especially attractive to investors since the COVID-19 pandemic."
In addition, to share CFDs, FP Markets offers over 10,000 trading instruments offering traders access to CFDs across Forex, Indices, Commodities, Stocks, and Cryptocurrencies, making it one of the largest offerings in the industry and offers 8 platforms including MT4, MT5 and Iress.
FP Markets was established in 2005. It is not publicly traded and does not operate a bank. FP Markets is authorised by one tier-1 regulator (high trust), one tier-2 regulator (average trust), and zero tier-3 regulators (low trust). FP Markets is authorised by the following tier-1 regulator: Australian Securities & Exchange Commission (ASIC). It has been awarded as the "Global Forex Value Broker" in consecutive years (2019, 2020) at the Global Forex Awards.